Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Uterine Fibroids Impact Up to 70% of African American Women Over the Age of 50
  • USA - English


News provided by

Precision Therapy Part of Imaging Healthcare Specialists

Apr 15, 2023, 11:30 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

San Diego, CA (PRWEB) April 15, 2023 -- Precision Therapy provides outpatient fibroid treatment in San Diego to host virtual event!

Uterine Fibroids are common. Up to 40% of women over the age of 35 have uterine fibroids, and that number increases to over 70% of women over 50. African American women are three times more likely to have fibroids than women of other ethnicities. Many women with fibroids do not experience any symptoms, but for some, the symptoms are so severe as to negatively impact their quality of life.

Sharjeel H. Sabir, MD, an interventional radiologist at Precision Therapy in San Diego, California, says, “Uterine Fibroids present with heavy menstrual cycles and bleeding in-between normal periods. For some women, this can result in low blood count, requiring iron or blood transfusions."

Post this

Sharjeel H. Sabir, MD, an interventional radiologist at Precision Therapy in San Diego, California, says, “Uterine Fibroids present with heavy menstrual cycles and bleeding in-between normal periods.”

He went on to say, “For some women, this can result in low blood count, requiring iron or blood transfusions. In addition to heavy periods, women can have bulk-related symptoms, such as pelvic pain, fullness, frequent trips to the bathroom, constipation and other related symptoms.”

There are many options for treating fibroids. Uterine Artery Embolization, also known as Uterine Fibroid Embolization or UFE is a safe, effective, outpatient procedure that can help most women suffering with uterine fibroids.

Precision Therapy will host a virtual event on April 27, 2023, at 8PM-PST, featuring Dr. Sabir, Uterine Fibroid Embolization, A Safe and Effective Treatment for Uterine Fibroids, which is free to attend online, and you can sign up today – Click here to register!

Uterine fibroids are benign (non-cancerous) tumors that grow from the uterus. They can range in size from as small as a grape to as large as a cantaloupe. Approximately 20-40% of women over age 35 have fibroids, and African-American women are at a greater risk for developing them.

Fibroids can result in pelvic pain or discomfort, urinary incontinence, frequent urination, and heavy menstrual bleeding. The location and size of uterine fibroids can affect the severity of these symptoms and impact quality of life. Fibroids are also hormonally sensitive, so the symptoms can be cyclical, just like with menstruation.

If fibroids are causing pain or other symptoms, a procedure to treat the fibroids may not be necessary. Pain medication and hormone treatment are options to relieve symptoms such as heavy menstrual bleeding and pelvic pain, although medication cannot eliminate fibroids and often has side effects, such as weight gain, vaginal dryness, and infertility.

The National Institute of Health states that most women will develop one or more uterine fibroids during their reproductive lifetime. African American women are younger at the onset of fibroids and have larger and more numerous tumors. Fibroids are the leading cause of hysterectomies.

Fibroids, if left untreated or undiagnosed, can lead to infertility, problems during pregnancy, and more aggressive surgical treatment. The most common symptoms include:

  • Heavy, prolonged bleeding
  • Pressure on the bladder causing urinary urgency
  • Pelvic pain – either constant, dull aches or shooting pains
  • Pain during intercourse if the fibroids are close to the cervix
  • Constipation
  • Abdominal bloating
  • Not able to conceive, or miscarriage
  • Anemia, causing fatigue

According to the Society of Interventional Radiology

UFE is a minimally invasive, image-guided, non-surgical treatment that is less painful and has a shorter recovery period than surgical options. The treatment is often just as effective as other uterine fibroid treatments.

The survey also found:

  • More than half of U.S. women (57 percent) do not think they are at risk of developing uterine fibroids.
  • A majority of women (62 percent) have never heard of UFE, with 44 percent of women diagnosed with uterine fibroids reporting that they have never heard of the treatment.
  • Among women who have heard of UFE, the majority (73 percent) did not first learn of it from their OB-GYN, the frontline provider of fibroid treatment. These women first l­­­earned about the treatment from other sources, including friends or family (32 percent), their own research (9 percent) or, particularly for younger women, from advertising (23 percent for all women 18+ and 38 percent for women 18–34).
  • One-fifth of women (20 percent) think hysterectomy is the only treatment for fibroids, and, of those diagnosed with fibroids, 11 percent still think hysterectomy is the only treatment option.

UFE is performed by an interventional radiologist who inserts a thin catheter into an artery at the groin or wrist. The doctor guides the catheter to the fibroid’s blood supply where small particles, about the size of grains of sand, are released to block the blood vessels feeding the fibroid, depriving it of nutrients. As a result, the fibroid shrinks and dies. After treatment, women should be back to their normal activity in about one week and should follow up with their interventional radiologist and their gynecologist a few weeks after that. Approximately nine out of 10 patients who undergo uterine fibroid embolization experience significant improvement, with many reporting their symptoms disappear completely.

ABOUT Precision Therapy

Precision Therapy is part of Imaging Healthcare Specialists, greater San Diego’s premier radiology team. The Precision Therapy clinic, operating out of a central San Diego location, provides a unique combination of medical expertise with a patient-focused team. In addition, the 11 IHS imaging centers from Oceanside to Chula Vista provide diagnostic and women’s imaging services, as well as preventive health screenings.

The Interventional Radiology specialists at Precision Therapy are among the region’s most experienced doctors at performing outpatient same day interventional procedures.

Sarah Woronieck, Precision Therapy Part of Imaging Healthcare Specialists, https://ihsprecisiontherapy.com/treatments/uterine-fibroid-embolization/, 1 619 922 2751, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.